Drug Screening Market worth $8.63 billion by 2022, at a CAGR of 10.2%

This study involved four major activities in estimating the current size of the drug screening market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Major Growth Drivers:Growth in this market is attributed to the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches.

On the other hand, bans on alcohol consumption in Islamic countries and the prohibition of drug testing at workplaces in certain regions are some major factors that may hinder the market growthExpected Revenue Growth:The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%Accessories to Fuel the Growth of Drug Screening Market :COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission.To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures.

Restrictions and lockdowns were also imposed in travel, business operations, public gatherings, and shelter-in-place orders, all of which have further impacted market growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773The rapid testing devices segment will witness the highest growth during the forecast period.Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables.

Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices.

However, the oral fluid testing devices segment is projected to register highest CAGR during the forecast period.

Drug screening is the process of chemical analysis designed to test patients for drug abuse and to test the use of drugs and substances that are not permitted in specific occupations or athletic competitions.The drug screening market based on products and services has been divided into drug screening products and drug screening services.

Based on sample type is segmented into the urine, breath, oral fluid, hair, and other samples.

The market based on end-users has been divided into workplaces, criminal justice systems, and law enforcement, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories.

The workplace testing segment is expected to be one of the major contributors to the market.For More Information Visit https://www.maximizemarketresearch.com/market-report/drug-screening-market/1352/ Geographically, North America is expected to be one of the largest markets for drug screening.

The growth in this region is attributed to factors such as increasing consumption of illicit drugs, government funding for curb drug abuse and the laws for supporting drug screening.The years that have been considered are:• Base year – 2016• Estimated year – 2017• Forecast period – 2016 to 2026Key Highlights:• Drug screening market analysis and forecast, in terms of value.• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the drug screening market.• Drug screening market segmentation on the basis product & services, sample type, end-user and geography (country-wise) has been provided.• Drug screening market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of the study.• Drug Screening market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the drug screening market are also profiled.Research Methodology:The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market.

KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market.

The Drug Screening market is expected to grow from USD 7.01 billion in 2019 to USD 6.66 billion by 2025 at a CAGR of 10.81% from 2019 to 2025.Drug screening tests support to analyze and diagnose biological samples like blood, hair, and urine and detect the presence of drugs of abuse or its metabolites in the body of patients.

Technological advancements in drug screening devices have allowed end-users to acquire accurate results.

In emerging economies like China, rising incidences of drug abuse amongst adults as well as the teenage population have hampered employment impeding the economic situation of the country proving to be the main factor contributing to industry growth.

Similarly, government bodies and not-for-profit organizations focus their efforts on funding drug screening initiatives thereby augmenting drug screening practices.

Although this industry has a high growth rate, certain social and political decisions may restrict market development.

The global market is segregated on the basis of Sample Type as Oral Fluid, Hair, Urine, Breath, and Other Samples.

Global Drug Screening Market was valued at US$ 4.10 Bn in 2019 and is expected to reach US$ 12.80 Bn by 2026, at a CAGR of 15.29 % during a forecast period.The Drug Screening Market Size 2021-2027 provides detailed competitive analysis, including market share, size, future scope, and future outlook.

Companies are investing heavily in new electric mopeds and scooters to make them more efficient.Get a Sample PDF of the Report at : Request Free Sample ReportList Of TOP KEY PLAYERS in Drug Screening Market Report are - • Mpd Inc.• Omega Laboratories• Premier Biotech• Psychemedics• Roche• Shimadzu• Siemens Healthineers• Labcorp• Quest Diagnostics• Alere• Orasure• Alfa Scientific Designs• Drägerwerk• Thermo Fisher Scientific• Drägerwerk• American Bio Medica Corporation• Sciteck, Inc.• Acm Global Laboratories• Carehealth America• Clinical Reference LaboratoryCOVID-19 Impact on Market:In December 2019, the COVID-19 epidemic began in Wuhan (China), and has been spreading rapidly around the world.

Due to travel bans and lockdowns, the COVID-19 epidemic has affected many countries' economies and industries.

This outbreak has caused major disruptions in the global food and drink industry, including supply chain breakdowns, cancellations of technology events, and office closures.

Segment by Application, The Drug Screening Market is divided into the United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

This report includes all aspects of the industry and a study of key players, including market leaders, followers, as well as new entrants.